SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-15-070210
Filing Date
2015-10-13
Accepted
2015-10-13 06:06:31
Documents
2
Period of Report
2015-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a15-20948_18ka.htm 8-K/A 31110
2 EX-10.2 a15-20948_1ex10d2.htm EX-10.2 158304
  Complete submission text file 0001104659-15-070210.txt   190607
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36033 | Film No.: 151154425
SIC: 2834 Pharmaceutical Preparations